The effects of alendronate and calcitonin on cytokines in postmenopausal osteoporosis: A 6-month randomized and controlled study

Yonsei Medical Journal

Volumn 44, Issue 1, 2003, Pages 99-109

  Gür, Ali ^a   Denli, Aziz ^a   Çevik, Remzi ^a   Nas, Kemal ^a   Karakoç, Mehmet ^a   Saraç, Aysegul Jale ^a  

^a DICLE UNIVERSITY   (Turkey)

Author keywords

Alendronate; And postmenauposal osteoporosis; Calcitonin; Calcium; Cytokines

Indexed keywords

ALENDRONIC ACID; CALCITONIN; CALCIUM; CYTOKINE; GLUCONOLACTATE CALCIUM; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; INTERLEUKIN 8; SALCATONIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE MINERAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PATHOGENESIS; POSTMENOPAUSE OSTEOPOROSIS; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; STATISTICAL SIGNIFICANCE;

EID: 0037296799     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2003.44.1.99     Document Type: Article

References (35)

1. Ershler WB, Harman SM, Keller ET. Immunologic aspects of osteoporosis. Developmental ad Comparative Immunology 1997;21:487-99.
2. Mac Donald BR, Gowen M. Cytokins and bone. Br J Rheumatol 1992;31:149-55.
3. Wallach S, Avioli LV, Feinblatt JD. Cytokines and bone metabolism. Calcif Tissue Int 1993;53:293-6.
4. Gruber HE. Bone and immune system. Proc Soc Exp Biol Med 1991;197:219-25.
5. Roodman GD. Role of cytokines in the regulation of bone resorption. Calcif Tissue Int 1993;53:94-8.
6. Tamura T. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin-6. Proc Natl Acad Sci USA 1993;90:11924-2877.
7. Jilka RL, Hangog G, Girasole G, Passeri G, Williams DC, Abrams JS, et al. Increased osteoclast development after estrogen loss: mediation by lnterleukin-6. Science 1992;257:88-91.
8. Passeri G, Girasole G, Jilka RL, Manolagas SC. Increased IL-6 production by murine bone marrow and bone cells after estrogen withdrawal. Endocrinology 1993;133:822-8.
9. Girasole G, Passeri G, Jilka RL, Manolagas SC. Interleukin-11: a new cytokine critical for osteoclast development. J Clin Invest 1994;93:1516-24.
10. Romas E, Udagawa N, Zhou H, Tamura T, Saito M, Taga T, et al. The role of gp130mediated signals in osteoclast development regulation of IL-11 production by osteoblasts and distribution of its receptor in bone marrow cultures. J Exp Med 1996;183:2581-91.
11. Natale VM, Filho WJ, Duarte AJS. Does the secretion of cytokines in the periphery reflect their role in bone metabolic diseases? Mech Ageing Dev 1997;94:14-23.
12. Roodman GD. Advances in bone biology: the osteoclast. Endocr Rev 1996;17:308-32.
13. Manolagas SCV, Jilka RL. Bone marrow, cytokines and bone remodelling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 1995;332:305-11.
14. Pacifici R. Estrogen, cytokines and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res 1996;11:1043-51.
15. Gur A, Denli A, Nas K, Cevik R, Karakoc M, Sarac AJ, et al. Possible pathogenetic role of new cytokines in postmenopausal osteoporosis and changes during calcitonin plus calcium therapy. Rheumatol Int 2002;22:194-8.
16. Horowitz MC. Cytokines and estrogen in bone: antiosteoporotic effects. Science 1993;260:626-7.
17. Pacifici R. Editorial: Cytokines, estrogen, and postmenopausal osteoporosis- The second decade. Endocrinology 1998;139:2659-61.
18. Pacifici R, Rifas L, Teitelbaum S, Slatopolsky E, McCracken R, Bergfeld M, et al. Spontaneous release of IL-1 from human blood monocytes reflects bone formation in idiopathic osteoporosis. Proc Natl Acad Sci USA 1987;84:4616-20.
19. Pacifici R, Rifas L, Mc Cracken R, Vered I, Mc Muartry C, Avioli LV, et al. Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release. Proc Natl Acad Sci USA 1989;86:2398-402.
20. Girasole G, Jilka RL, Passeri G, Boswell S, Border G, Williams DC, et al. 17- β-Estradiol inhibits IL-6 production by bon marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiostoporotic effects of estrogens. J Clin Invest 1992;89:883-91.
21. Chen JT, Maruo N, Kato T. Serum level of soluble IL-6 receptor, not IL-6, is correlated with bone resorption markers and lumbar bone mineral density after menopause (Abstract). J Bone Miner Res 1996;10:347.
22. Papadopoulos NG, Georganas K, Skoutellas V, Konstantellos E, Lyritis GP. Correlation of interleukin-6 serum levels ith bone density in postmenopusal women. Clin Rheumatol 1997;16:162-5.
23. Kimble RB, Srivastava S, Ross FP, Matayoshi A, Pacifici R. Estrogen deficiency increases the ability of stromal cells to support osteoclastogenesis via an IL-1 and TNF mediated stimulation of M-CSF production. J Biol Chem 1996;271:28890-7.
24. Bellido T, Jilka RL, Boyce BF, Girasole G, Broxmeyer H, Dalrymple SA, et al. Regulation of interleukin-6, osteoklastogenesis, and bone mass by androgens. The role of the androgen receptor. J Clin Invest 1995;94:2886-95.
25. Morita Y, Yamamura M, Kawashima M, Harada S, Tsuji K, Shibuya K, et al. Flow cytometric single-cell analysis of cytokine production by CD4+ T cells in synovial tissue and peripheral blood from patients with rheumatoid arthritis. Arthritis Rheum 1998;41:1669-76.
26. Steiner G, Tohidast-Akrad M, Witzmann G, Vesely M, Studnicka-Benke A, Gal A, et al. Cytokine production by synovial T cells in rheumatoid arthritis. Rheumatology (Oxford) 1999;38:202-13.
27. Partsch G, Wagner E, Leeb BF, Broll H, Dunky A, Smolen JS. T cell derived cytokines in psoriatic arthritis, synovial fluids. Ann Rheum Dis 1998;57:691-3.
28. Toivanen A. Reactive arthritis and Reiter's Syndrome: history and clinical features. In: Klippel HJ, Dieppe PA, editors. Rheumatology, 2nd ed. London: Mosby; 1998. 6. 11.1-18.
29. Fan PT, Yan Yuu DT. Reiter's Syndrome. In: Kelley WN, Harris ED, Ruddy S, Sledge CB, editors. Textbook of Rheumatology, 5th ed. Philadelphia: WB Saunders Company; 1997. p.983-97.
30. Gladman DD. Psoriatic arthritis. In: Maddison PJ, Isenberg DA, Woo P, Glass DN, editors. Oxford Textbook of Rheumatology. 2nd ed. Oxford: Oxford University Press; 1998. p.1071-84.
31. Angeletti RH, D'Amico T, Ashok S, Russell J. The chemokine interleukin-8 regulates parathyroid secretion. J Bone Miner Res 1998;13:1232-7.
32. Dynarello CA, Moldawer LL. Proinflammatory and Anti-inflammatory Cytokines in Rheumatoid Arthritis, 2nd ed. Thousand Oaks: Amgen Inc; 2000. p.23-75.
33. Katsikis PD, Chu CK, Brennan FM, Maini RN, Feldmann M. Immunoregulatory role of interleukin-10 in rheumatoid arthritis. J Exp Med 1994;179;1517-27.
34. Armour KE, Van't Hof RJ, Grabowski PS, Reid DM, Ralston SH. Evidence for a pathogenic role of nitric oxide in inflammation-induced osteoporosis. J Bone Miner Res 1999;14:2137-42.
35. van't Hof RJ, Ralston SH. Nitric oxide and bone. Immunology 2001;103:255-61.